相关实验视频
Updated: Jan 16, 2026

10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
11.5K
重定位仅用格拉姆阳性阿达罗衍生的抗菌剂为宽谱抗生素
Salvatore Princiotto1, Luigi Cutarella2, Alessandra Fortuna3
1Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, via Celoria 2, 20133 Milan, Italy.
Antibiotics (Basel, Switzerland)
|September 27, 2025
概括
研究人员开发了阿达罗衍生物,如SPL207,以对抗抗生素耐药性. SPL207破坏细菌膜,显示出对抗格拉姆阴性病原体的潜力,并在耐药菌株中与素产生协同作用.
科学领域:
- 药用化学 医学化学
- 抗微生物药物发现 抗微生物药物发现
- 分子药理学分子药理学
背景情况:
- 全球抗生素耐药性日益增加,对公众健康构成重大威胁.
- 仅格拉姆阳性 (GPO) 抗生素对格拉姆阴性细菌的有效性有限,原因是外膜透问题.
- 世界卫生组织 (WHO) 已经确定了需要新的治疗策略的优先病原体.
研究的目的:
- 设计和合成新型阿达罗衍生物,以克服格兰负外膜障碍.
- 评估这些新化合物的抗菌活性和破坏膜的能力.
- 探索与现有抗生素对抗耐药菌株的潜在协同效应.
主要方法:
- 合成具有正电荷组的阿达罗衍生物化合物.
- 确定针对格拉姆阳性和格拉姆阴性细菌的最小抑制度 (MIC).
- 光测试和共聚焦显微镜以评估膜透性破坏.
- 分子动力学 (MD) 模拟以阐明膜相互作用的机制.
主要成果:
- 衍生品SPL207显示MIC值在8-64μM之间对测试的细菌.
- SPL207有效地破坏了格拉姆阴性细菌的外膜和内膜完整性.
- 当SPL207与胆固醇结合用于抗胆固醇耐药的P. aeruginosa*菌株时,观察到显著的协同作用.
- 医学模拟显示,SPL207作为膜不稳定剂,增强离子扩散和脂质不稳定.
结论:
- 阿达罗衍生物显示出作为一种针对膜完整性的新类抗菌剂的前景.
- SPL207展示了一种概念验证,用于克服格拉姆阴性外膜挑战.
- 需要进一步进行结构优化,以达到针对多药耐药 (MDR) 病原体的临床相关MIC值.
相关概念视频
Antibiotic Selection
59.4K
Overview
59.4K
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K
Antimicrobial Effectiveness
908
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
908
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K

